bullish

MIRA:新たなデータは新たな買収による有望性を示している

372 Views26 Jun 2025 00:00
Issuer-paid
MIRA Pharmaceuticals(MIRA)社スポンサー調査レポート
What is covered in the Full Insight:
  • MIRA Pharmaceuticalsの概要
  • SKNYの最近の買収とSKNY-1の将来性
  • 画期的な治療薬としてのケタミルの可能性
  • 市場の潜在力と財務見通し
  • 結論と投資の検討
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
chart-bar
Price Chart(Sign Up to Access)
analytics-chart
  • Loading...
x